BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2027301)

  • 21. Effect of recombinant interferons on colony formation of blast progenitors in acute myeloblastic leukemia.
    Takanashi M; Motoji T; Oshimi K; Mizoguchi H
    Exp Hematol; 1987 Oct; 15(9):946-51. PubMed ID: 2443379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the proliferative activity and sensitivity to cytosine arabinoside of leukemic blast progenitors in acute myeloblastic leukemia at diagnosis and in relapse.
    Nara N; Tohda S; Suzuki T; Nagata K; Tanikawa S; Imai Y; Tomiyama J; Shiina S
    Acta Haematol; 1992; 88(1):17-21. PubMed ID: 1414157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combinations of stem cell factor with other hematopoietic growth factors enhance growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia.
    Inatomi Y; Toyama K; Clark SC; Shimizu K; Miyauchi J
    Cancer Res; 1994 Jan; 54(2):455-62. PubMed ID: 7506123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the in vitro growth of blast progenitors from acute myeloblastic leukemia patients by transforming growth factor-beta (TGF-beta).
    Nara N; Tohda S; Nagata K; Suzuki T; Yamashita Y
    Leukemia; 1989 Aug; 3(8):572-7. PubMed ID: 2473359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.
    Geissler K; Tricot G; Leemhuis T; Walker E; Broxmeyer HE
    Cancer Res; 1989 Jun; 49(11):3057-62. PubMed ID: 2497971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement by transforming growth factor-beta 1 (TGF-beta 1) of the proliferation of leukemic blast progenitors stimulated with IL-3.
    Suzuki T; Bessho M; Hirashima K; Tohda S; Nagata K; Morio T; Imai Y; Nara N
    J Cell Physiol; 1991 Sep; 148(3):396-403. PubMed ID: 1717497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity of hematopoietic progenitors of acute myeloblastic leukemia to new compounds derived from marine organisms.
    Lishner M; Shur I; Bleiberg I; Rudi A; Kashman Y; Fabian I
    Leukemia; 1995 Sep; 9(9):1543-8. PubMed ID: 7658723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of humoral and cellular factors on the growth of blast progenitors of acute myeloblastic leukemia in serum-free culture.
    Maruyama Y; Tohda S; Nagata K; Suzuki T; Murohashi I; Nara N
    Hematol Pathol; 1990; 4(3):115-23. PubMed ID: 1701766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia.
    Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
    Exp Hematol; 1995 Aug; 23(9):1030-4. PubMed ID: 7543415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
    Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
    Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
    Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture.
    Miyauchi J; Kelleher CA; Wong GG; Yang YC; Clark SC; Minkin S; Minden MD; McCulloch EA
    Leukemia; 1988 Jun; 2(6):382-7. PubMed ID: 2453760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular concentrations of mitoxantrone in leukemic cells in vitro vs in vivo.
    Sundman-Engberg B; Tidefelt U; Gruber A; Paul C
    Leuk Res; 1993 Apr; 17(4):347-52. PubMed ID: 8487583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro effects of bisantrene on fresh clonogenic leukemia cells: a preliminary study on 15 cases.
    Visani G; Rizzi S; Tosi P; Cenacchi A; Gamberi B; Lemoli RM; Papadopulu P; Tura S
    Haematologica; 1990; 75(6):527-31. PubMed ID: 2098293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligation of cell surface CD38 protein with agonistic monoclonal antibody induces a cell growth signal in myeloid leukemia cells.
    Konopleva M; Estrov Z; Zhao S; Andreeff M; Mehta K
    J Immunol; 1998 Nov; 161(9):4702-8. PubMed ID: 9794400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells.
    Kerangueven F; Sempere C; Tabilio A; Mannoni P
    Eur Cytokine Netw; 1990; 1(2):99-107. PubMed ID: 2129395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of hyperthermia on both primary proliferation and self-renewal of human leukemic progenitor cells in vitro: its application to in vitro purging.
    Moriyama Y; Nikkuni K; Saito H; Aoki A; Kishi K; Takahashi M; Shibata A
    Leukemia; 1991 Apr; 5(4):332-5. PubMed ID: 2027300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML.
    Park S; Chapuis N; Bardet V; Tamburini J; Gallay N; Willems L; Knight ZA; Shokat KM; Azar N; Viguié F; Ifrah N; Dreyfus F; Mayeux P; Lacombe C; Bouscary D
    Leukemia; 2008 Sep; 22(9):1698-706. PubMed ID: 18548104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.